289 related articles for article (PubMed ID: 9160608)
1. Personality dimensions in panic disorder before and after effective treatment.
Starcevic V; Uhlenhuth EH
Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
[No Abstract] [Full Text] [Related]
2. Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
Sheehan DV; Raj AB; Harnett-Sheehan K; Dorotheo J; Sheehan MF; Trehan R; Knapp E; Swiontek A; Coleman B
Anxiety; 1996; 2(1):40-6. PubMed ID: 9160598
[No Abstract] [Full Text] [Related]
3. [Clinical picture and treatment of agoraphobia with panic disorder].
Litvintsev SV; Reznik AM; Kvashnina NV; Arbuzov AL; Krylov KE
Voen Med Zh; 2003 Jun; 324(6):53-9. PubMed ID: 12916423
[No Abstract] [Full Text] [Related]
4. A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.
Ravaris CL; Friedman MJ; Hauri PJ; McHugo GJ
J Clin Psychopharmacol; 1991 Dec; 11(6):344-50. PubMed ID: 1770152
[TBL] [Abstract][Full Text] [Related]
5. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
Pols H; Verburg K; Hauzer R; Meijer J; Griez E
Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
[TBL] [Abstract][Full Text] [Related]
6. [Panic disorder and agoraphobia: what is effective?].
Bandelow B; Sievert K; Röthemeyer M; Hajak G; Broocks A; Rüther E
Fortschr Neurol Psychiatr; 1995 Nov; 63(11):451-64. PubMed ID: 8575719
[TBL] [Abstract][Full Text] [Related]
7. Ondansetron in the treatment of panic disorder.
Schneier FR; Garfinkel R; Kennedy B; Campeas R; Fallon B; Marshall R; O'Donnell L; Hogan T; Liebowitz MR
Anxiety; 1996; 2(4):199-202. PubMed ID: 9160623
[No Abstract] [Full Text] [Related]
8. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
9. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.
Sheehan DV; Sheehan KH; Raj BA
Psychopharmacol Bull; 2007; 40(2):63-81. PubMed ID: 17514187
[TBL] [Abstract][Full Text] [Related]
10. Alpidem in the treatment of panic disorder.
Schneier FR; Carrasco JL; Hollander E; Campeas R; Fallon B; Saoud JB; Feerick J; Liebowitz MR
J Clin Psychopharmacol; 1993 Apr; 13(2):150-3. PubMed ID: 8096527
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy.
Brambilla F; Bellodi L; Perna G
Psychiatry Res; 1999 Dec; 89(1):21-7. PubMed ID: 10643874
[TBL] [Abstract][Full Text] [Related]
13. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
[TBL] [Abstract][Full Text] [Related]
14. Efficacy studies of alprazolam in panic disorder.
Spiegel DA
Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
[TBL] [Abstract][Full Text] [Related]
15. Treatment of panic disorder.
Cassano GB; Toni C; Musetti L
Adv Biochem Psychopharmacol; 1992; 47():449-60. PubMed ID: 1509926
[No Abstract] [Full Text] [Related]
16. Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam.
Bond AJ; Curran HV; Bruce MS; O'Sullivan G; Shine P
J Affect Disord; 1995 Dec; 35(3):117-23. PubMed ID: 8749839
[TBL] [Abstract][Full Text] [Related]
17. Generalized anxiety disorder versus panic disorder: participation in controlled efficacy trials.
Mavissakalian MR; Zamar N
Compr Psychiatry; 2000; 41(4):253-8. PubMed ID: 10929792
[TBL] [Abstract][Full Text] [Related]
18. [Personality disorders in patients with panic disorder].
Alfonso Suárez S; Fernández Vega F
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1992; 20(6):241-5. PubMed ID: 1288064
[TBL] [Abstract][Full Text] [Related]
19. Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders.
Klein E; Malel D; Zilberman I; Lenox RH
Isr J Psychiatry Relat Sci; 1997; 34(4):265-9. PubMed ID: 9409083
[TBL] [Abstract][Full Text] [Related]
20. Diazepam versus alprazolam for the treatment of panic disorder.
Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
